Hybrid Closed-Loop Insulin Pump Technology Can Be Safely Used in the Inpatient Setting
Authors' conclusion
This preliminary case series review indicates that continued use of HCL technology in the hospital is safe. Moreover, glycemic control in HCL users was comparable with that in those using insulin pump with manual settings and those converted to basal-bolus insulin therapy.
Study context
- Population
- Patients using hybrid closed-loop (HCL) technology on admission to the authors' hospital, June 1, 2020 – June 30, 2021final analysis
- Participants
- 71 patients
- Exposure
- Continued HCL use vs manual pump use vs pump removal during hospitalisation
- Outcome
- Inpatient glycaemic control
Methodological detailssingle-centre, records review
- Single-centre
- Records review
Main finding
As reported in the abstract
- Patient-stay mean glucose, frequency of hyperglycaemic measurements and frequency of hypoglycaemic events similar between all groups (pairwise comparisons)
Observational data: associations, not effects.
Safety
Adverse events (DKA, pump site complications or infection, equipment malfunction)
- No adverse events reported
Original publication
Hybrid Closed-Loop Insulin Pump Technology Can Be Safely Used in the Inpatient Setting. Endocr Pract. Published 15 November 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →